Pathomechanisms of harlequin ichthyosis and ABCA transporters in human diseases

Archives of Dermatology

Volumn 142, Issue 7, 2006, Pages 914-918

  Akiyama, Masashi ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN BINDING PROTEIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

GENE MUTATION; GENE THERAPY; GENETIC DISORDER; HUMAN; ICHTHYOSIS; PRIORITY JOURNAL; REVIEW;

ATP-BINDING CASSETTE TRANSPORTERS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ICHTHYOSIS, LAMELLAR; INFANT, NEWBORN; MUTATION; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 33746097414     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.142.7.914     Document Type: Review

References (25)

1. Lefèvre C, Audebert S, Jobard F, et al. Mutations in the transporter ABCA12 are associated with lamellar ichthyosis type 2. Hum Mol Genet. 2003;12:2369-2378.
2. Akiyama M, Sugiyama-Nakagiri Y, Sakai K, et al. Mutations in ABCA12 in harlequin ichthyosis and functional rescue by corrective gene transfer. J Clin Invest. 2005;115:1777-1784.
3. Kelsell DP, Norgett EE, Unsworth H, et al. Mutations in ABCA12 underlie the severe congenital skin disease harlequin ichthyosis. Am J Hum Genet. 2005;76:794-803.
4. Haftek M, Cambazard F, Dhouailly D, et al. A longitudinal study of a harlequin infant presenting clinically as non-bullous congenital ichthyosiform erythroderma. Br J Dermatol. 1996;135:448-453.
5. Dale BA, Holbrook KA, Fleckman P, Kimball JR, Brumbaugh S, Sybert VP. Heterogeneity in harlequin ichthyosis, an inborn error of epidermal keratinization: variable morphology and structural protein expression and a defect in lamellar granules. J Invest Dermatol. 1990;94:6-18.
6. Milner ME, O'Guin WM, Holbrook KA, Dale BA. Abnormal lamellar granules in harlequin ichthyosis. J Invest Dermatol. 1992;99:824-829.
7. Akiyama M, Kim DK, Main DM, Otto CE, Holbrook KA. Characteristic morphologic abnormality of harlequin ichthyosis detected in amniotic fluid cells. J Invest Dermatol. 1994;102:210-213.
8. Akiyama M, Dale BA, Smith LT, Shimizu H, Holbrook KA. Regional difference in expression of characteristic abnormality of harlequin ichthyosis in affected fetuses. Prenat Diagn. 1998;18:425-436.
9. Akiyama M, Yoneda K, Kim SY, Koyama H, Shimizu H. Cornified cell envelope proteins and keratins are normally distributed in harlequin ichthyosis. J Cutan Pathol. 1996;23:571-575.
10. Akiyama M, Kim SY, Yoneda K, Shimizu H. Expression of transglutaminase 1 (transglutaminase K) in harlequin ichthyosis. Arch Dermatol Res. 1997;289:116-119.
11. Yamano G, Funahashi H, Kawanami O, et al. ABCA3 is a lamellar body membrane protein in human lung alveolar type II cells. FEBS Lett. 2001;508:221-225.
12. Borst P, Elferink RO. Mammalian ABC transporters in health and disease. Annu Rev Biochem. 2002;71:537-592.
13. Peelman F, Labeur C, Vanloo B, et al. Characterization of the ABCA transporter subfamily: identification of prokaryotic and eukaryotic members, phylogeny and topology. J Mol Biol. 2003;325:259-274.
14. Uitto J, Pulkkinen L, Ringpfeil F. Molecular genetics of pseudoxanthoma elasticum: a metabolic disorder at the environment-genome interface? Trends Mol Med. 2001;7:13-17.
15. Uitto J. The gene family of ABC transporters: novel mutations, new phenotypes. Trends Mol Med. 2005;11:341-343.
16. Annilo T, Shulenin S, Chen ZQ, et al. Identification and characterization of a novel ABCA subfamily member, ABCA12, located in the lamellar ichthyosis region on 2q34. Cytogenet Genome Res. 2002;98:169-176.
17. Shulenin S, Nogee LM, Annilo T, Wert SE, Whitsett JA, Dean M. ABCA3 gene mutations in newborns with fatal surfactant deficiency. N Engl J Med. 2004;350:1296-1303.
18. Akiyama M, Suzumori K, Shimizu H. Prenatal diagnosis of harlequin ichthyosis by the examinations of keratinized hair canals and amniotic fluid cells at 19 weeks' estimated gestational age. Prenat Diagn. 1999;19:167-171.
19. Shimizu A, Akiyama M, Ishiko A, Yoshiike T, Suzumori K, Shimizu H. Prenatal exclusion of harlequin ichthyosis: potential pitfalls in the timing of the fetal skin biopsy. Br J Dermatol. 2005;153:811-814.
20. Tsuji-Abe Y, Akiyama M, Nakamura H, et al. DNA-based prenatal exclusion of bullous congenital ichthyosiform erythroderma at the early stage, 10 to 11 weeks' of pregnancy, in two consequent siblings. J Am Acad Dermatol. 2004;51:1008-1011.
21. Uitto J, Pfendner E, Jackson LG. Probing the fetal genome: progress in noninvasive prenatal diagnosis. Trends Mol Med. 2003;9:339-343.
22. Wells D, Delhantry JD. Preimplantation genetic diagnosis: applications of molecular medicine. Trends Mol Med. 2001;7:23-30.
23. Choate KA, Medalie DA, Morgan JR, Khavari PA. Corrective gene transfer in the human skin disorder lamellar ichthyosis. Nat Med. 1996;2:1263-1267.
24. Hengge UR, Bardenheuer W. Gene therapy and the skin. Am J Med Genet C Semin Med Genet. 2004;131C:93-100.
25. Ohyama M, Ota T, Aoki M, et al. Suppression of the immune response against exogenous desmoglein 3 in desmoglein 3 knockout mice: an implication for gene therapy. J Invest Dermatol. 2003;120:610-615.